| Filed On | Filing |
|---|---|
| 08 Sep 2026 |
8-K/A: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
As previously reported, the Company previously sold and issued to Streeterville Capital, LLC, a Utah limited liability company (“Streeterville”), a Secured Promissory Note with an original issuance date of June 9, 2025 in the original pr... |
| 25 Aug 2025 |
8-K/A: Completion of Acquisition or Disposition of Assets; Other Events
On June 10, 2025 (the “Closing Date”), Vivos Pharmaceuticals, Inc. (“Vivos” or the “Company”) closed its previously announced transaction to acquire the net operating assets of R.D. Prabhu-Lata K. Shete MDs, LTD., a Nevada professional c... |
Loading...
